ADAR1 Capital Management »

Spruce Biosciences shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Spruce Biosciences (SPRB) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Spruce Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Spruce Biosciences held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spruce Biosciences by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $287k 365k 0.79

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Spruce Biosciences

RiverVest Venture Management
Carlyle
Rock Springs Capital Management
Acadian Asset Management
Vanguard Group
Altium Capital Management
Sands Capital Ventures
Renaissance Technologies
Almitas Capital
Geode Capital Management
BlackRock
BlackRock
Bridgeway Capital Management
Citadel Advisors
Superstring Capital Management

View all funds holding Spruce Biosciences